Gene Signature–Based Approach Identified MEK1/2 as a Potential Target Associated With Relapse After Anti-TNFα Treatment for Crohn's Disease. Issue 6 (18th May 2018) - Gamo, Kanae; Okuzono, Yuumi; Yabuki, Masato; Ochi, Takashi; Sugimura, Kyoko; Sato, Yosuke; Sagara, Masaki; Hayashi, Hiroki; Ishimura, Yoshimasa; Nishimoto, Yutaka; Murakawa, Yusuke; Shiokawa, Zenyu; et al.